ScholarLens Back to search
1955•Canadian Journal of Biochemistry and PhysiologyRequires access

RELIABILITY OF THE RIBOFLAVIN EXCRETION TECHNIQUE IN DETERMINING AVAILABILITY OF COATED TABLETS

D. G. Chapman, Jackie A. Campbell

Open publisher page 5 citations

Abstract

Further studies have been carried out to assess the reliability of the human bio-assay technique using the excretion of riboflavin to estimate the availability of sugar-coated tablets. Using eight individuals, it has been shown that for 1, 3, and 5 mgm. amounts of riboflavin the excretion is the same whether these amounts are taken as a single dose or in 10 small doses totalling the same amount. For doses of riboflavin of 1, 3, 5, 7.5, and 10 mgm. a linear relationship was found to exist between the amount ingested and excreted. The equation for this dose response line was found to be y = 0.580x − 0.610. The intercept − 0.610 was significantly different from zero, indicating that the line did not pass through the origin. The results furnish further evidence of the validity of the urinary excretion of riboflavin for determining the physiological availability of coated tablets.

About this research paper

What this paper is about

Further studies have been carried out to assess the reliability of the human bio-assay technique using the excretion of riboflavin to estimate the availability of sugar-coated tablets. Using eight individuals, it has been shown that for 1, 3, and 5 mgm. amounts of riboflavin the excretion is the same whether these amounts are taken as a single dose or in 10 small doses totalling the same amount. For doses of riboflavin of 1, 3, 5, 7.5, and 10 mgm. a linear relationship was found to exist between the amount ingested and excreted. The equation for this dose response line was found to be y = 0.580x − 0.610. The intercept − 0.610 was significantly different from zero, indicating that the line did not pass through the origin. The results furnish further evidence of the validity of the urinary excretion of riboflavin for determining the physiological availability of coated tablets.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Further studies have been carried out to assess the reliability of the human bio-assay technique using the excretion of riboflavin to estimate the availability of sugar-coated tablets. Using eight individuals, it has been shown that for 1, 3, and 5 mgm. amounts of riboflavin the excretion is the same whether these amounts are taken as a single dose or in 10 small doses totalling the same amount. For doses of riboflavin of 1, 3, 5, 7.5, and 10 mgm. a linear relationship was found to exist between the amount ingested and excreted. The equation for this dose response line was found to be y = 0.580x − 0.610. The intercept − 0.610 was significantly different from zero, indicating that the line did not pass through the origin. The results furnish further evidence of the validity of the urinary excretion of riboflavin for determining the physiological availability of coated tablets.

Key concepts: Riboflavin, Excretion, Chemistry, Chromatography, Food science, Biochemistry

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
RELIABILITY OF THE RIBOFLAVIN EXCRETION TECHNIQUE IN DETERMINING AVAILABILITY OF COATED TABLETS — Research Paper | ScholarLens